19-13207858-CCTGCTGCTGCTGCTGCTGCTGCTGCTGCTG-CCTGCTGCTGCTGCTGCTG
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_001127222.2(CACNA1A):c.6964_6975delCAGCAGCAGCAG(p.Gln2322_Gln2325del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000856 in 1,431,502 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00072 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00087 ( 2 hom. )
Consequence
CACNA1A
NM_001127222.2 conservative_inframe_deletion
NM_001127222.2 conservative_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.785
Genes affected
CACNA1A (HGNC:1388): (calcium voltage-gated channel subunit alpha1 A) Voltage-dependent calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, and gene expression. Calcium channels are multisubunit complexes composed of alpha-1, beta, alpha-2/delta, and gamma subunits. The channel activity is directed by the pore-forming alpha-1 subunit, whereas, the others act as auxiliary subunits regulating this activity. The distinctive properties of the calcium channel types are related primarily to the expression of a variety of alpha-1 isoforms, alpha-1A, B, C, D, E, and S. This gene encodes the alpha-1A subunit, which is predominantly expressed in neuronal tissue. Mutations in this gene are associated with 2 neurologic disorders, familial hemiplegic migraine and episodic ataxia 2. This gene also exhibits polymorphic variation due to (CAG)n-repeats. Multiple transcript variants encoding different isoforms have been found for this gene. In one set of transcript variants, the (CAG)n-repeats occur in the 3' UTR, and are not associated with any disease. But in another set of variants, an insertion extends the coding region to include the (CAG)n-repeats which encode a polyglutamine tract. Expansion of the (CAG)n-repeats from the normal 4-18 to 21-33 in the coding region is associated with spinocerebellar ataxia 6. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 19-13207858-CCTGCTGCTGCTG-C is Benign according to our data. Variant chr19-13207858-CCTGCTGCTGCTG-C is described in ClinVar as [Likely_benign]. Clinvar id is 1711465.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000723 (107/147902) while in subpopulation SAS AF= 0.00128 (6/4704). AF 95% confidence interval is 0.000771. There are 0 homozygotes in gnomad4. There are 49 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High AC in GnomAd4 at 107 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.6964_6975delCAGCAGCAGCAG | p.Gln2322_Gln2325del | conservative_inframe_deletion | 47/47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.6982_6993delCAGCAGCAGCAG | p.Gln2328_Gln2331del | conservative_inframe_deletion | 48/48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.6970_6981delCAGCAGCAGCAG | p.Gln2324_Gln2327del | conservative_inframe_deletion | 47/47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.6967_6978delCAGCAGCAGCAG | p.Gln2323_Gln2326del | conservative_inframe_deletion | 47/47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.6967_6978delCAGCAGCAGCAG | p.Gln2323_Gln2326del | conservative_inframe_deletion | 47/47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.6931_6942delCAGCAGCAGCAG | p.Gln2311_Gln2314del | conservative_inframe_deletion | 46/46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.6826_6837delCAGCAGCAGCAG | p.Gln2276_Gln2279del | conservative_inframe_deletion | 46/46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389 | c.*50_*61delCAGCAGCAGCAG | 3_prime_UTR_variant | 47/47 | 5 | ENSP00000489992.1 | ||||
CACNA1A | ENST00000637432 | c.*176_*187delCAGCAGCAGCAG | 3_prime_UTR_variant | 48/48 | 5 | ENSP00000490617.1 | ||||
CACNA1A | ENST00000635895 | c.*176_*187delCAGCAGCAGCAG | 3_prime_UTR_variant | 47/47 | 5 | ENSP00000490323.1 | ||||
CACNA1A | ENST00000638009 | c.*176_*187delCAGCAGCAGCAG | 3_prime_UTR_variant | 47/47 | 1 | ENSP00000489913.1 | ||||
CACNA1A | ENST00000637276 | c.*176_*187delCAGCAGCAGCAG | 3_prime_UTR_variant | 46/46 | 5 | ENSP00000489777.1 |
Frequencies
GnomAD3 genomes AF: 0.000724 AC: 107AN: 147800Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
107
AN:
147800
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000872 AC: 1119AN: 1283600Hom.: 2 AF XY: 0.000888 AC XY: 561AN XY: 631724
GnomAD4 exome
AF:
AC:
1119
AN:
1283600
Hom.:
AF XY:
AC XY:
561
AN XY:
631724
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000723 AC: 107AN: 147902Hom.: 0 Cov.: 0 AF XY: 0.000681 AC XY: 49AN XY: 72002
GnomAD4 genome
AF:
AC:
107
AN:
147902
Hom.:
Cov.:
0
AF XY:
AC XY:
49
AN XY:
72002
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Sep 01, 2024 | CACNA1A: BS1 - |
CACNA1A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 04, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at